On the Heels of FDA Investments, PhRMA Funds Regulatory Science Initiative
Posted 05 June 2014 | By
In recent years, the US Food and Drug Administration (FDA) has made substantial investments in regulatory science initiatives, spending millions on research, establishing new academic programs, and partnering with dozens of institutions in the pursuit of new ways to bring safe and effective drugs to market more quickly.
But the agency isn't the only one interested in advancing regulatory science.
In an announcement this week, the influential pharmaceutical industry trade group PhRMA said it would be establishing and funding a regulatory science fellowship position at Georgetown University's Program for Regulatory Science and Medicine, which has been one of FDA's affiliated Centers of Excellence in Regulatory Science and Innovation (CERSI) since 2011.
PhRMA and Georgetown University's new postgraduate Fellowship in Regulatory Science position is intended to offer fellows the opportunity to engage with industry, regulators and academics in the hopes of helping to advance regulatory science.
According to the application for the program:
"The Fellowship in Regulatory Science will provide the scientific training needed to modernize and improve the way medical products are reviewed and evaluated. The fellow will be awarded a one-year term, with renewal options, to conduct research, learn, teach, and mentor students. The Fellowship in Regulatory Science will develop researchers and scholars in this field to reach their fullest potential in advancing innovative research and public health. "
In a statement, PhRMA said the program "signifies PhRMA’s desire to promote and enable the extraordinary value that encompasses regulatory science."
Applications for the fellowship will be accepted through 30 June 2014. An email of intent must be sent by 20 June 2014.